148 related articles for article (PubMed ID: 2769668)
21. Urinary and synovial pyridinium crosslink concentrations in patients with rheumatoid arthritis and osteoarthritis.
Sinigaglia L; Varenna M; Binelli L; Bartucci F; Arrigoni M; Ferrara R; Abbiati G
Ann Rheum Dis; 1995 Feb; 54(2):144-7. PubMed ID: 7702405
[TBL] [Abstract][Full Text] [Related]
22. Bone resorption and inflammatory inhibition efficacy of intermittent cyclical etidronate therapy in rheumatoid arthritis.
Hasegawa J; Nagashima M; Yamamoto M; Nishijima T; Katsumata S; Yoshino S
J Rheumatol; 2003 Mar; 30(3):474-9. PubMed ID: 12610804
[TBL] [Abstract][Full Text] [Related]
23. [Assay of cross-linking molecules of collagen (pyridinolines) in the study of the degradation of bone tissue and articular cartilage].
Uebelhart D; Delmas PD
Pathol Biol (Paris); 1993 Dec; 41(10):951-61. PubMed ID: 8159476
[TBL] [Abstract][Full Text] [Related]
24. Urinary excretion of pyridinium crosslinks of collagen correlated with joint damage in arthritis.
Astbury C; Bird HA; McLaren AM; Robins SP
Br J Rheumatol; 1994 Jan; 33(1):11-5. PubMed ID: 8162449
[TBL] [Abstract][Full Text] [Related]
25. Infliximab inhibits bone resorption by circulating osteoclast precursor cells in patients with rheumatoid arthritis and ankylosing spondylitis.
Gengenbacher M; Sebald HJ; Villiger PM; Hofstetter W; Seitz M
Ann Rheum Dis; 2008 May; 67(5):620-4. PubMed ID: 17720725
[TBL] [Abstract][Full Text] [Related]
26. A comparison of methods for measuring serum and urinary markers of bone metabolism in cats.
DeLaurier A; Jackson B; Pfeiffer D; Ingham K; Horton MA; Price JS
Res Vet Sci; 2004 Aug; 77(1):29-39. PubMed ID: 15120950
[TBL] [Abstract][Full Text] [Related]
27. The urinary excretion of pyridinoline and deoxypyridinoline during rheumatoid arthritis therapy with infliximab.
Ostanek L; Pawlik A; Brzosko I; Brzosko M; Sterna R; Droździk M; Gawrońska-Szklarz B
Clin Rheumatol; 2004 Jun; 23(3):214-7. PubMed ID: 15168147
[TBL] [Abstract][Full Text] [Related]
28. Urinary excretion of glucosyl-galactosyl pyridinoline: a specific biochemical marker of synovium degradation.
Gineyts E; Garnero P; Delmas PD
Rheumatology (Oxford); 2001 Mar; 40(3):315-23. PubMed ID: 11285380
[TBL] [Abstract][Full Text] [Related]
29. Is there a psoriatic osteopathy? -- the activity of bone resorption in psoriatics is related to inflammatory joint process.
Hein G; Schmidt F; Barta U; Müller A
Eur J Med Res; 1999 May; 4(5):187-92. PubMed ID: 10336408
[TBL] [Abstract][Full Text] [Related]
30. Changes in synovial membrane and joint effusion volumes after intraarticular methylprednisolone. Quantitative assessment of inflammatory and destructive changes in arthritis by MRI.
Ostergaard M; Stoltenberg M; Gideon P; Sørensen K; Henriksen O; Lorenzen I
J Rheumatol; 1996 Jul; 23(7):1151-61. PubMed ID: 8823685
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of urinary pyridinium crosslinks and their derivatives in multiple myeloma.
Samani KK; Brazier M; Mathiot C; Kamel S; Jamart J; Jaubert J; Blanc M; Azaïs I; Facon T; Leleu X
Ann Hematol; 2005 Jan; 84(1):19-24. PubMed ID: 15338198
[TBL] [Abstract][Full Text] [Related]
32. Physiological variations in the urinary excretion of pyridinium crosslinks of collagen.
McLaren AM; Isdale AH; Whiting PH; Bird HA; Robins SP
Br J Rheumatol; 1993 Apr; 32(4):307-12. PubMed ID: 8461924
[TBL] [Abstract][Full Text] [Related]
33. Bone resorption in anorexia nervosa and rehabilitated patients.
Valtueña S; Di Mattei V; Rossi L; Polito A; Cuzzolaro M; Branca F
Eur J Clin Nutr; 2003 Feb; 57(2):260-5. PubMed ID: 12571657
[TBL] [Abstract][Full Text] [Related]
34. Serum concentrations of interleukin 6, osteocalcin, intact parathyroid hormone, and markers of bone resorption in patients with rheumatoid arthritis.
Al-Awadhi A; Olusi S; Al-Zaid N; Prabha K
J Rheumatol; 1999 Jun; 26(6):1250-6. PubMed ID: 10381038
[TBL] [Abstract][Full Text] [Related]
35. [Components of the extracellular tissue matrix as potential "markers" of connective tissue, cartilage and bone metabolism in diseases of the locomotor system].
Seibel MJ
Z Rheumatol; 1989; 48(1):6-18. PubMed ID: 2652939
[TBL] [Abstract][Full Text] [Related]
36. Bone metabolism changes during anti-TNF-alpha therapy in patients with active rheumatoid arthritis.
Seriolo B; Paolino S; Sulli A; Ferretti V; Cutolo M
Ann N Y Acad Sci; 2006 Jun; 1069():420-7. PubMed ID: 16855169
[TBL] [Abstract][Full Text] [Related]
37. Relationship between bone markers and knee cartilage volume in healthy men.
Wang Y; Ebeling PR; Hanna F; O'Sullivan R; Cicuttini FM
J Rheumatol; 2005 Nov; 32(11):2200-4. PubMed ID: 16265703
[TBL] [Abstract][Full Text] [Related]
38. Biochemical markers for assessing skeletal growth.
Robins SP
Eur J Clin Nutr; 1994 Feb; 48 Suppl 1():S199-209. PubMed ID: 8005087
[TBL] [Abstract][Full Text] [Related]
39. Simultaneous free and glycosylated pyridinium crosslink determination in urine: validation of an HPLC-fluorescence method using a deoxypyridinoline homologue as internal standard.
Monticelli E; Aman CS; Costa ML; Rota P; Bogdan D; Allevi P; Cighetti G
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Sep; 879(26):2764-71. PubMed ID: 21855424
[TBL] [Abstract][Full Text] [Related]
40. Plasma adiponectin in patients with active, early, and chronic rheumatoid arthritis who are steroid- and disease-modifying antirheumatic drug-naive compared with patients with osteoarthritis and controls.
Laurberg TB; Frystyk J; Ellingsen T; Hansen IT; Jørgensen A; Tarp U; Hetland ML; Hørslev-Petersen K; Hornung N; Poulsen JH; Flyvbjerg A; Stengaard-Pedersen K
J Rheumatol; 2009 Sep; 36(9):1885-91. PubMed ID: 19684150
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
